News Conference News EuroPCR 2024 Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids Michael O'Riordan May 15, 2024
Presentation EuroPCR 2024 First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2 Presenter: Ole De Backer May 15, 2024
News Conference News TAVI Use Rising in Young US Patients, Yet Another Analysis Shows Yael L. Maxwell May 06, 2024
News Conference News ACC 2024 Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6 Yael L. Maxwell April 08, 2024
News Conference News STS 2024 TAVI, SAVR Almost Equally Performed in California Patients Under 60 Yael L. Maxwell February 01, 2024